載入...
Development and characterization of liposomal formulation of bortezomib
Bortezomib is a proteasome inhibitor used for the treatment of multiple myeloma. The poor pharmacokinetic profile and off-target adverse effects provide a strong incentive to develop drug delivery systems for bortezomib. In the past, liposomal encapsulation has been proven to improve the therapeutic...
Na minha lista:
| 發表在: | Int J Pharm X |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Elsevier
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6733293/ https://ncbi.nlm.nih.gov/pubmed/31517276 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijpx.2019.100011 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|